{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:20:58Z","timestamp":1785860458300,"version":"3.56.0"},"reference-count":32,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,16]]},"DOI":"10.20945\/2359-4292-2024-0217","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T16:18:57Z","timestamp":1734365937000},"source":"Crossref","is-referenced-by-count":4,"title":["Prognostic significance of the pan-immune-inflammation value (PIV) in patients with differentiated thyroid carcinoma"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-6063","authenticated-orcid":false,"given":"Yusuf","family":"\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6473-4164","authenticated-orcid":false,"given":"Muhammet","family":"Kocaba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7990-8350","authenticated-orcid":false,"given":"Melia","family":"Karak\u00f6se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9908-7449","authenticated-orcid":false,"given":"Mustafa","family":"Kulaksizo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-9625","authenticated-orcid":false,"given":"Feridun","family":"Karakurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20241216161854_B1","unstructured":"Thyroid-Global cancer observatory. Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/32-thyroid-fact-sheet.pdf. Accessed on: 14 Apr 2024.","journal-title":"Thyroid-Global cancer observatory"},{"issue":"1","key":"key20241216161854_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. doi: 10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"4","key":"key20241216161854_B3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ijc.11275","article-title":"Incidence and survival of Swedish patients with differentiated thyroid cancer","volume":"106","author":"Lundgren","year":"2003","unstructured":"Lundgren CI, Hall P, Ekbom A, Frisell J, Zedenius J, Dickman PW. Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer. 2003;106(4):569-73. doi: 10.1002\/ijc.11275","journal-title":"Int J Cancer"},{"issue":"6","key":"key20241216161854_B4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/thy.2017.0102","article-title":"Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?","volume":"27","author":"Tuttle","year":"2017","unstructured":"Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? Thyroid. 2017;27(6):751-6. doi: 10.1089\/thy.2017.0102","journal-title":"Thyroid"},{"issue":"2","key":"key20241216161854_B5","first-page":"106","article-title":"Distant metastases of differentiated thyroid cancer: diagnosis, treatment and outcome","volume":"10","author":"Toubert","year":"2007","unstructured":"Toubert ME, Hindie E, Rampin L, Al-Nahhas A, Rubello D. Distant metastases of differentiated thyroid cancer: diagnosis, treatment and outcome. Nucl Med Rev Cent East Eur. 2007;10(2):106-9.","journal-title":"Nucl Med Rev Cent East Eur"},{"issue":"8","key":"key20241216161854_B6","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91(8):2892-9. doi: 10.1210\/jc.2005-2838","journal-title":"J Clin Endocrinol Metab"},{"issue":"7203","key":"key20241216161854_B7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-44. doi: 10.1038\/nature07205","journal-title":"Nature"},{"key":"key20241216161854_B8","doi-asserted-by":"crossref","first-page":"2373868","DOI":"10.1155\/2018\/2373868","article-title":"Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis","volume":"2018","author":"Ventriglia","year":"2018","unstructured":"Ventriglia J, Petrillo A, Huerta Alv\u00e1ro M, Laterza MM, Savastano B, Gambardella V, et al. Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis. Gastroenterol Res Pract. 2018;2018:2373868. doi: 10.1155\/2018\/2373868","journal-title":"Gastroenterol Res Pract"},{"key":"key20241216161854_B9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijsu.2018.05.030","article-title":"Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis","volume":"55","author":"Tan","year":"2018","unstructured":"Tan D, Fu Y, Tong W, Li F. Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis. Int J Surg. 2018;55:128-38. doi: 10.1016\/j.ijsu.2018.05.030","journal-title":"Int J Surg"},{"issue":"1","key":"key20241216161854_B10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12876-020-1167-x","article-title":"The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis","volume":"20","author":"Cao","year":"2020","unstructured":"Cao W, Yao X, Cen D, Zhi Y, Zhu N, Xu L. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20(1):16. doi: 10.1186\/s12876-020-1167-x","journal-title":"BMC Gastroenterol"},{"issue":"34","key":"key20241216161854_B11","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","article-title":"Systemic immune-inflammation index for predicting prognosis of colorectal cancer","volume":"23","author":"Chen","year":"2017","unstructured":"Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261-72. doi: 10.3748\/wjg.v23.i34.6261","journal-title":"World J Gastroenterol"},{"issue":"3","key":"key20241216161854_B12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41416-020-0894-7","article-title":"The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials","volume":"123","author":"Fuc\u00e0","year":"2020","unstructured":"Fuc\u00e0 G, Guarini V, Antoniotti C, Morano F, Moretto R, Corallo S, et al. The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials. Br J Cancer. 2020;123(3):403-9. doi: 10.1038\/s41416-020-0894-7","journal-title":"Br J Cancer"},{"issue":"3","key":"key20241216161854_B13","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1530\/ERC-17-0453","article-title":"8th edition of the AJCC\/TNM staging system of thyroid cancer: what to expect (ITCO#2)","volume":"25","author":"Lamartina","year":"2018","unstructured":"Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, et al. 8th edition of the AJCC\/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr Relat Cancer. 2018;25(3):L7-L11. doi: 10.1530\/ERC-17-0453","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"key20241216161854_B14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.bjc.6602702","article-title":"Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model","volume":"93","author":"Schmidt","year":"2005","unstructured":"Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, et al. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer. 2005;93(3):273-278. doi: 10.1038\/sj.bjc.6602702","journal-title":"Br J Cancer"},{"issue":"8","key":"key20241216161854_B15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jso.23753","article-title":"Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer","volume":"110","author":"Ishizuka","year":"2014","unstructured":"Ishizuka M, Oyama Y, Abe A, Kubota K. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer. J Surg Oncol. 2014;110(8):935-41. doi: 10.1002\/jso.23753","journal-title":"J Surg Oncol"},{"issue":"7","key":"key20241216161854_B16","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jama.1982.03320320040027","article-title":"Absolute granulocyte, lymphocyte, and moncyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach","volume":"247","author":"Bruckner","year":"1982","unstructured":"Bruckner HW, Lavin PT, Plaxe SC, Storch JA, Livstone EM. Absolute granulocyte, lymphocyte, and moncyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach. JAMA. 1982;247(7):1004-6. doi: 10.1001\/jama.247.7.1004","journal-title":"JAMA"},{"issue":"13","key":"key20241216161854_B17","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.ejca.2011.02.015","article-title":"Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes","volume":"47","author":"Sajadieh","year":"2011","unstructured":"Sajadieh A, Mouridsen MR, Selmer C, Intzilakis T, Nielsen OW, Haugaard SB. Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes. Eur J Cancer. 2011;47(13):2015-22. doi: 10.1016\/j.ejca.2011.02.015","journal-title":"Eur J Cancer"},{"issue":"6","key":"key20241216161854_B18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S2213-8587(16)30277-7","article-title":"Leveraging the immune system to treat advanced thyroid cancers","volume":"5","author":"French","year":"2017","unstructured":"French JD, Bible K, Spitzweg C, Haugen BR, Ryder M. Leveraging the immune system to treat advanced thyroid cancers. Lancet Diabetes Endocrinol. 2017;5(6):469-81. doi: 10.1016\/S2213-8587(16)30277-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"key20241216161854_B19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759-71. doi: 10.1038\/nrc3611","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"key20241216161854_B20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1189\/jlb.5MR1216-508R","article-title":"Neutrophils as active regulators of the immune system in the tumor microenvironment","volume":"102","author":"Shaul","year":"2017","unstructured":"Shaul ME, Fridlender ZG. Neutrophils as active regulators of the immune system in the tumor microenvironment. J Leukoc Biol. 2017;102(2):343-9. doi: 10.1189\/jlb.5MR1216-508R","journal-title":"J Leukoc Biol"},{"issue":"5","key":"key20241216161854_B21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/bjc.2017.214","article-title":"Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling","volume":"117","author":"Jiang","year":"2017","unstructured":"Jiang L, Luan Y, Miao X, Sun C, Li K, Huang Z, et al. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling. Br J Cancer. 2017;117(5):695-703. doi: 10.1038\/bjc.2017.214","journal-title":"Br J Cancer"},{"issue":"3","key":"key20241216161854_B22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","unstructured":"Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN. Cancer Cell. 2009;16(3):183-94. doi: 10.1016\/j.ccr.2009.06.017","journal-title":"Cancer Cell"},{"key":"key20241216161854_B23","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150. Published 2016 Jul 6. doi: 10.1038\/ncomms12150","journal-title":"Nat Commun"},{"issue":"6","key":"key20241216161854_B24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s11154-023-09845-x","article-title":"Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis [published correction appears in Rev Endocr Metab Disord. 2023 Nov 18;:]","volume":"24","author":"Russo","year":"2023","unstructured":"Russo E, Guizzardi M, Canali L, Gaino F, Costantino A, Mazziotti G, et al. Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis [published correction appears in Rev Endocr Metab Disord. 2023 Nov 18;:]. Rev Endocr Metab Disord. 2023;24(6):1205-16. doi: 10.1007\/s11154-023-09845-x","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"key20241216161854_B25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/jso.26089","article-title":"Diagnostic and prognostic value of preoperative systemic inflammatory markers in anaplastic thyroid cancer","volume":"122","author":"Zhang","year":"2020","unstructured":"Zhang L, Luo H, Wang L, Liu Y, Rui S, Wu Z, et al. Diagnostic and prognostic value of preoperative systemic inflammatory markers in anaplastic thyroid cancer. J Surg Oncol. 2020;122(5):897-905. doi: 10.1002\/jso.26089","journal-title":"J Surg Oncol"},{"issue":"7","key":"key20241216161854_B26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/cancers13071625","article-title":"Site-Specific Metastasis and Survival in Papillary Thyroid Cancer: The Importance of Brain and Multi-Organ Disease","volume":"13","author":"Toraih","year":"2021","unstructured":"Toraih EA, Hussein MH, Zerfaoui M, Attia AS, Marzouk Ellythy A, et al. Site-Specific Metastasis and Survival in Papillary Thyroid Cancer: The Importance of Brain and Multi-Organ Disease. Cancers (Basel). 2021;13(7):1625. Published 2021 Apr 1. doi: 10.3390\/cancers13071625","journal-title":"Cancers (Basel)"},{"issue":"7","key":"key20241216161854_B27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00268-013-2006-9","article-title":"Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades","volume":"37","author":"Goffredo","year":"2013","unstructured":"Goffredo P, Sosa JA, Roman SA. Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades. World J Surg. 2013;37(7):1599-605. doi: 10.1007\/s00268-013-2006-9","journal-title":"World J Surg"},{"issue":"1","key":"key20241216161854_B28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/thy.2015.0375","article-title":"Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas","volume":"26","author":"Jeon","year":"2016","unstructured":"Jeon MJ, Kim WG, Choi YM, Kwon H, Lee YM, Sung TY, et al. Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas. Thyroid. 2016;26(1):161-8. doi: 10.1089\/thy.2015.0375","journal-title":"Thyroid"},{"issue":"2","key":"key20241216161854_B29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1507\/endocrj.51.219","article-title":"Follicular thyroid carcinomas with lung metastases: a 23-year retrospective study","volume":"51","author":"Lin","year":"2004","unstructured":"Lin JD, Chao TC, Hsueh C. Follicular thyroid carcinomas with lung metastases: a 23-year retrospective study. Endocr J. 2004;51(2):219-25. doi: 10.1507\/endocrj.51.219","journal-title":"Endocr J"},{"issue":"7","key":"key20241216161854_B30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/thy.2010.0353","article-title":"Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma","volume":"21","author":"Sugino","year":"2011","unstructured":"Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, et al. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid. 2011;21(7):751-7. doi: 10.1089\/thy.2010.0353","journal-title":"Thyroid"},{"issue":"4","key":"key20241216161854_B31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00268-017-4206-1","article-title":"Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis","volume":"42","author":"Vuong","year":"2018","unstructured":"Vuong HG, Duong UNP, Pham TQ, Tran HM, Oishi N, Mochizuki K, et al. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis. World J Surg. 2018;42(4):1005-17. doi: 10.1007\/s00268-017-4206-1","journal-title":"World J Surg"},{"issue":"12","key":"key20241216161854_B32","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2010.0178","article-title":"Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system","volume":"20","author":"Tuttle","year":"2010","unstructured":"Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010;20(12):1341-9. doi: 10.1089\/thy.2010.0178","journal-title":"Thyroid"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T16:19:04Z","timestamp":1734365944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/prognostic-significance-of-the-pan-immune-inflammation-value-piv-in-patients-with-differentiated-thyroid-carcinoma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":32,"alternative-id":["10.20945\/2359-4292-2024-0217"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2024-0217","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e240217"}}